000165537 001__ 165537
000165537 005__ 20240321115501.0
000165537 0247_ $$2doi$$a10.1186/s12888-021-03603-6
000165537 0247_ $$2pmid$$apmid:34922483
000165537 0247_ $$2pmc$$apmc:PMC8684227
000165537 0247_ $$2altmetric$$aaltmetric:120251531
000165537 037__ $$aDZNE-2022-01681
000165537 041__ $$aEnglish
000165537 082__ $$a610
000165537 1001_ $$00000-0002-6104-7836$$aSelinus, Eva Norén$$b0
000165537 245__ $$aInattention and hyperactivity symptoms in childhood predict physical activity in adolescence.
000165537 260__ $$aHeidelberg$$bSpringer$$c2021
000165537 3367_ $$2DRIVER$$aarticle
000165537 3367_ $$2DataCite$$aOutput Types/Journal article
000165537 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1711017547_32502
000165537 3367_ $$2BibTeX$$aARTICLE
000165537 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000165537 3367_ $$00$$2EndNote$$aJournal Article
000165537 520__ $$aPhysical activity has been documented to influence several aspects of physical and mental health. Growing evidence shows that physical activity can improve attention. Less is known about how symptoms of inattention and hyperactivity / impulsivity in childhood are associated with physical activity in adolescence. We aimed to explore this relationship further.We used a cohort of 3949 Swedish children (1884 boys and 2065 girls) with data collected at ages 9 (or 12) and 15. We investigated the influence of symptoms of inattention and hyperactivity / impulsivity in childhood - age 9/12 (inattention and hyperactivity/impulsivity separately) on self-rated physical activity at age 15, using multiple logistic regression models. We considered potential confounders such as sex, parental education level, physical activity in childhood and neurodevelopmental comorbidity. A cluster robust sandwich estimator was applied to adjust the standard errors for the nested twin data when computing the regression models.Symptoms of inattention in childhood (9/12) predicted less physical activity in adolescence (age 15) (OR = 0.83 CI = 0.78-0.89), whereas the opposite was true for hyperactivity/impulsivity (OR = 1.08 CI = 1.02-1.10). These associations still remained when taking possible confounders into account including neurodevelopmental and neurodevelopmental related comorbidity.These findings support the importance of helping children and adolescents with inattention symptoms to engage in physical activity in suitable settings.
000165537 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000165537 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000165537 650_7 $$2Other$$aADHD
000165537 650_7 $$2Other$$aHyperactivity
000165537 650_7 $$2Other$$aInattention
000165537 650_7 $$2Other$$aLongitudinal
000165537 650_7 $$2Other$$aNeurodevelopmental problems
000165537 650_7 $$2Other$$aPhysical activity
000165537 650_2 $$2MeSH$$aAdolescent
000165537 650_2 $$2MeSH$$aAttention
000165537 650_2 $$2MeSH$$aAttention Deficit Disorder with Hyperactivity: diagnosis
000165537 650_2 $$2MeSH$$aChild
000165537 650_2 $$2MeSH$$aCohort Studies
000165537 650_2 $$2MeSH$$aExercise
000165537 650_2 $$2MeSH$$aFemale
000165537 650_2 $$2MeSH$$aHumans
000165537 650_2 $$2MeSH$$aMale
000165537 650_2 $$2MeSH$$aPsychomotor Agitation
000165537 7001_ $$aDurbeej, Natalie$$b1
000165537 7001_ $$0P:(DE-2719)9000829$$aZhan, Yiqiang$$b2$$udzne
000165537 7001_ $$aLichtenstein, Paul$$b3
000165537 7001_ $$aLundström, Sebastian$$b4
000165537 7001_ $$aEkblom, Maria$$b5
000165537 773__ $$0PERI:(DE-600)2050438-X$$a10.1186/s12888-021-03603-6$$gVol. 21, no. 1, p. 629$$n1$$p629$$tBMC psychiatry$$v21$$x1471-244X$$y2021
000165537 8564_ $$uhttps://pub.dzne.de/record/165537/files/DZNE-2022-01681.pdf$$yOpenAccess
000165537 8564_ $$uhttps://pub.dzne.de/record/165537/files/DZNE-2022-01681.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000165537 909CO $$ooai:pub.dzne.de:165537$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000165537 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000829$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000165537 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000165537 9141_ $$y2021
000165537 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-09
000165537 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000165537 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC PSYCHIATRY : 2021$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-14T16:20:14Z
000165537 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000165537 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-14T16:20:14Z
000165537 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000165537 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000165537 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000165537 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-09
000165537 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000165537 9201_ $$0I:(DE-2719)1910005$$kAG Zhan$$lNeuroepidemiology$$x0
000165537 980__ $$ajournal
000165537 980__ $$aVDB
000165537 980__ $$aUNRESTRICTED
000165537 980__ $$aI:(DE-2719)1910005
000165537 9801_ $$aFullTexts